Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.52 USD | +5.41% | +6.54% | -26.58% |
May. 29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
May. 28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.58% | 5.24B | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-11.32% | 32.75B | |
+63.50% | 26.47B | |
-20.17% | 14.25B | |
-6.35% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.92% | 9.11B |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- Transcript : BridgeBio Pharma, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 03